Have you been diagnosed with Graves’ disease or Hashimoto’s disease? Both are common conditions that may require recurring laboratory testing in conjunction with medical treatment. If you require regular screenings, you can order your own Microsomal TPO Antibody screening directly without the need for a doctor’s order or going through your insurance. Save time any money by ordering directly with My Lab ReQuest!

Order Your Own Microsomal TPO Antibody test for $32

Order & Pay for your tests in 4 easy steps.

  • 1 Select Tests
  • 2 Personal Preferences
  • 3 Authorization
  • 4 Payment & Schedule

*Available under Thyroid Screening & Monitoring category on test menu page

Order your Microsomal TPO Antibody screening at any of your local Sonora Quest Patient Service Centers. Place your order, schedule your appointment, and pay for your testing all online. Once your test has been completed, use our online results portal to quickly and easily access your results within just a few days. Order your test today and take charge of your health with My Lab ReQuest!



Why order your own Microsomal TPO Antibody test with My Lab ReQuest?

Checklist Icon
  • 1) To take charge of your health and have the most accurate and up-to-date information to proactively manage your health and make educated decisions

  • 2) You prefer the convenience and the time savings of ordering directly

  • 3) Your insurance does not pay for laboratory testing


Since the passage of the law in 2015 that allows for consumers in Arizona to order their own lab tests, thousands of patients have used our My Lab ReQuest service to take charge of their health and make more informed healthcare decisions. Our Microsomal TPO Antibody screening is one of four screenings we offer for you to check and monitor your thyroid health.

Patients choose Sonora Quest Laboratories to meet their lab testing needs for a wide range of reasons, including:

Award-Winning Quality

As the nation's largest integrated laboratory system, Sonora Quest Laboratories delivers award-winning quality services every day to more than 23,000 patients across Arizona. We are the #1 bioscience company in Arizona, according to Ranking Arizona, and we are also the only healthcare company to even win the Arizona Governor's Award for Quality. Most importantly, we are accredited by the College of American Pathologists (CAP), the organization whose accreditation ensures the highest standard of care for laboratory patients.

Convenient Locations

Schedule an appointment or walk in to any of our 75+ Patient Service Centers located across Arizona! We have over 45 locations in Metro Phoenix, 14 locations in Tucson and Southern Arizona, and various other locations across Northern and Western Arizona. Moreover, several of our locations are conveniently located inside of Safeway markets so that you can plan your screening around your trip to your neighborhood grocery store.


 

Learn More about Graves' Disease and Hashimoto's Disease



What are Grave's disease and Hashimoto's disease?

Graves’ disease is an autoimmune disease that attacks the thyroid gland. In a person with Graves’ disease, antibodies bind to receptors on thyroid cells and lead to the excess production of thyroid hormones. The overproduction of thyroid hormones is what leads to hyperthyroidism. Graves’ disease is the most common cause of hyperthyroidism and affects about 1 in 200 people in the United States, according to the National Institute of Diabetes and Digestive and Kidney Diseases.

Hashimoto’s disease is also an autoimmune disease that attacks the thyroid gland. In a person with Hashimoto’s disease, chronic inflammation develops and the body is unable to produce the necessary amount of thyroid hormones. As a result, Hashimoto’s disease commonly leads to hypothyroidism. In the United States, Hashimoto’s disease affects about 1 in 5 people, according to the National Institute of Diabetes and Digestive and Kidney Diseases.



What are the risk factors for Grave's disease and Hashimoto's disease?

Anyone can develop Graves’ disease. However, certain groups are at higher risk. People in the following groups are at higher risk for Graves’ disease:

  • Women

  • People with a family history

  • People with autoimmune diseases such as type 1 diabetes

  • People under emotional or physical stress

  • Pregnant women

  • People who smoke


For Hashimoto’s disease, people in the following groups are at higher risk:

  • Women

  • Middle-aged people

  • People with a family history

  • People with autoimmune diseases such as type 1 diabetes

  • People that have been exposed to high levels of radiation


What are the symptoms of Graves' disease and Hashimoto's disease?

The symptoms for Graves’ disease are similar to the symptoms of hypothyroidism. Some of these symptoms are fatigue, weight gain, dry skin, and an intolerance to cold. In addition to these symptoms, Graves’ disease can cause inflammation of the eyes and Graves’ dermopathy, a condition in which there is a reddening of the skin in front of the shins. 

In people with Hashimoto’s disease, the disease progresses very slowly and it can even take years before any distinguishable symptoms are present. When symptoms do become present, they most often include fatigue, weight gain, dry skin, and muscle aches.



Who should get tested for Gravess disease and Hashimoto's disease?

If you have sign or symptoms of Graves’ disease or Hashimoto’s disease, please contact your doctor. He or she can review your medical history and evaluate your symptoms to determine what testing may be needed to accurately diagnose your condition. 

If you have already been diagnosed with a thyroid disease such a Graves’ disease or Hashimoto’s disease, the Microsomal TPO Antibody test can be helpful in monitoring your condition. However, if attempting to establish a diagnosis, a thyroid screen (TSH test) should be considered for an initial screening.



How are Graves' disease and Hashimoto's disease diagnosed?

The diagnosis of both Graves’ Disease and Hashimoto’s disease is typically made through the combination of a physical examination and laboratory testing.



What are the treatments for Graves' disease and Hashimoto's disease?

Available treatment options for Graves’ disease include medication, radioiodine therapy, and thyroid surgery. Of these treatment options, radioiodine therapy is the most common form of treatment for Graves’ disease.

Hashimoto’s disease is commonly treated with medication if a doctor believes that the thyroid is damaged to the extent that treatment is warranted.

As always, a doctor can best evaluate your condition and review your medical history to assist you with coming up with the course of treatment that best fits your needs.



*It is solely your responsibility to promptly discuss all laboratory test results with a physician. Neither Sonora Quest Laboratories nor its Medical Director will provide interpretation, counseling, consulting, or care recommendations on the basis of any laboratory results provided to you.  

Order Your Own Microsomal TPO Antibody Test 

Order a Microsomal TPO Antibody test for $32 & pay for your test in 4 easy steps. 

  • 1 Select Tests
  • 2 Personal Preferences
  • 3 Authorization
  • 4 Payment & Schedule

*Available under Thyroid Screening & Monitoring category on test menu page

OR

Print a blank form to fill out & bring to a patient service center.

Additional Thyroid Screenings

T3, Free

Used primarily to help diagnose hyperthyroidism and may be used to help monitor treatment of a person with a known thyroid disorder

T4, Free

Used to help evaluate thyroid function and diagnose thyroid diseases, including hyperthyroidism and hypothyroidism, usually after discovering that the thyroid stimulating hormone (TSH) level is abnormal.

Thyroid Screen (TSH, High Sensitivity)

Used to detect problems affecting the thyroid gland.

My Lab ReQuest Patient Testimonial


“I believe My Lab ReQuest is the first generation of true patient centered healthcare in America. One in which a ‘person’, not a patient, can monitor and manage to some extent, and hopefully a greater extent in the near future, their own physiological process and status.”